Cargando…
Toujie Quwen granule used with conventional western therapy for coronavirus disease 2019: A protocol for systematic review and meta-analysis
BACKGROUND: Coronavirus disease 2019 (COVID-19) is an epidemic infectious disease resulted from 2019 novel coronavirus (2019-nCoV). Up till now, COVID-19 has swept globally. Currently, due to many high-profiled benefits, clinical studies on Toujie Quwen granule (TJQW) have been increasing. The aim o...
Autores principales: | Sun, Peng, Yan, Dongmei, Li, Bin, Tang, Liping, Xu, Lingxia, Wang, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213269/ https://www.ncbi.nlm.nih.gov/pubmed/34128895 http://dx.doi.org/10.1097/MD.0000000000026370 |
Ejemplares similares
-
Therapeutic mechanism of Toujie Quwen granules in COVID-19 based on network pharmacology
por: Huang, Ying, et al.
Publicado: (2020) -
Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia
por: Ye, Miaobo, et al.
Publicado: (2021) -
Efficacy and safety of Jinhua Qinggan granules for coronavirus disease 2019 (COVID-19): A protocol of a systematic review and meta-analysis
por: Chen, Hao, et al.
Publicado: (2020) -
The efficacy and safety of Jinhua Qinggan granule (JHQG) in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis
por: Zhang, Qiongshuai, et al.
Publicado: (2020) -
Moxibustion for stable chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Wang, Yanping, et al.
Publicado: (2021)